ATE145899T1 - Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen - Google Patents

Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen

Info

Publication number
ATE145899T1
ATE145899T1 AT92402566T AT92402566T ATE145899T1 AT E145899 T1 ATE145899 T1 AT E145899T1 AT 92402566 T AT92402566 T AT 92402566T AT 92402566 T AT92402566 T AT 92402566T AT E145899 T1 ATE145899 T1 AT E145899T1
Authority
AT
Austria
Prior art keywords
production
pharmaceutical compositions
derivatives
trimetazidine
trimetazidine derivatives
Prior art date
Application number
AT92402566T
Other languages
English (en)
Inventor
Gilbert Regnier
Jean-Paul Vilaine
Nicole Villeneuve
Jean-Pierre Bidouard
Jean-Pierre Iliou
Albert Lenaers
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE145899T1 publication Critical patent/ATE145899T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/58—Radicals substituted by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT92402566T 1991-09-18 1992-09-18 Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen ATE145899T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9111469A FR2681324B1 (fr) 1991-09-18 1991-09-18 Nouveaux derives de la trimetazidine, leur procede de preparation et les compositions pharmaceutiques les contenant.

Publications (1)

Publication Number Publication Date
ATE145899T1 true ATE145899T1 (de) 1996-12-15

Family

ID=9417037

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92402566T ATE145899T1 (de) 1991-09-18 1992-09-18 Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen

Country Status (14)

Country Link
US (1) US5283246A (de)
EP (1) EP0533579B1 (de)
JP (1) JPH0676396B2 (de)
AT (1) ATE145899T1 (de)
AU (1) AU647964B2 (de)
CA (1) CA2078520C (de)
CY (1) CY2142B1 (de)
DE (1) DE69215626T2 (de)
DK (1) DK0533579T3 (de)
ES (1) ES2097299T3 (de)
FR (1) FR2681324B1 (de)
GR (1) GR3022322T3 (de)
NZ (1) NZ244370A (de)
ZA (1) ZA927165B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0598123A4 (de) * 1991-07-19 1995-02-15 Zeria Pharm Co Ltd Piperazinderivate und diese enthaltende arzneimittel.
FR2703048B1 (fr) * 1993-03-24 1996-01-05 Adir Nouveaux composes n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant.
DE69525763T2 (de) * 1994-04-11 2002-10-02 Chugai Seiyaku K.K., Tokio/Tokyo 4,6-DI-t-BUTYL-2,3-DIHYDROBENZOTHIOPHENE, DIE LDL OXIDATION HEMMEN
IL117149A0 (en) * 1995-02-23 1996-06-18 Schering Corp Muscarinic antagonists
ATE221057T1 (de) * 1995-08-21 2002-08-15 Takeda Chemical Industries Ltd Quinoneverbindung, seine herstellung und anwendung.
FR2757164B1 (fr) * 1996-12-16 1999-01-22 Adir Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JPH10265386A (ja) * 1997-03-21 1998-10-06 Toshio Sato 抗酸化作用を有する抗アレルギー剤
EP1829535A3 (de) * 1999-10-27 2007-10-24 Tanox, Inc. Gewebefaktor-Antagonisten und Verfahren zu deren Verwendung
US6608066B1 (en) * 1999-10-27 2003-08-19 Sunol Molecular Corporation Tissue factor antagonists and methods of use thereof
FR2802424B1 (fr) * 1999-12-17 2002-02-15 Adir Comprime matriciel permettant la liberation prolongee de trimetazidine apres administration par voie orale
FR2805463B1 (fr) * 2000-02-25 2003-01-24 Adir UTILISATION DE LA TRIMETAZIDINE POUR L'OBTENTION DE COMPOSITIONS PHARMACEUTIQUES DESTINEES A INHIBER L'ACYL-CoA ACETYLTRANSFERASE
FR2827284B1 (fr) * 2001-07-16 2003-10-31 Servier Lab Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2003037323A2 (en) * 2001-10-26 2003-05-08 MEDIGENE AG Gesellschaft für Molekularbiologische Kardiologie und Onkologie Inhibitors of the fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction
WO2007116243A2 (en) * 2006-04-10 2007-10-18 Mintails Limited Method for treating fibromyalgia and related conditions
US20110274751A1 (en) 2010-05-04 2011-11-10 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Trimetazidine formulation with different release profiles
CN103554057B (zh) * 2013-11-13 2016-04-20 武汉武药科技有限公司 曲美他嗪衍生物及其制备方法
WO2018093839A1 (en) 2016-11-15 2018-05-24 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Therapy for mitochondrial fatty acid beta-oxidation and transport disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187706A (en) * 1968-06-07 1970-04-15 Ciba Ltd 2-Aminomethyl-2,3-Dihydro-Benzofurans
US4100285A (en) * 1976-04-09 1978-07-11 Nippon Shinyaku Co., Ltd. N-substituted trialkoxybenzyl piperazine derivatives
CA1286299C (en) * 1985-05-13 1991-07-16 Johji Yamahara 3,4-dihydrobenzopyran derivatives and medicinal uses thereof
WO1987005020A1 (fr) * 1986-02-21 1987-08-27 Kuraray Co., Ltd. Derives de 3,4-dihydro-2h-benzopyranne et leur usage medicinal

Also Published As

Publication number Publication date
GR3022322T3 (en) 1997-04-30
NZ244370A (en) 1994-09-27
EP0533579B1 (de) 1996-12-04
CA2078520C (fr) 2001-04-24
JPH05194451A (ja) 1993-08-03
JPH0676396B2 (ja) 1994-09-28
DE69215626D1 (de) 1997-01-16
ES2097299T3 (es) 1997-04-01
DE69215626T2 (de) 1997-06-12
AU2453792A (en) 1993-03-25
CA2078520A1 (fr) 1993-03-19
CY2142B1 (en) 2002-06-21
US5283246A (en) 1994-02-01
EP0533579A1 (de) 1993-03-24
FR2681324A1 (fr) 1993-03-19
FR2681324B1 (fr) 1993-10-29
AU647964B2 (en) 1994-03-31
DK0533579T3 (da) 1997-05-26
ZA927165B (en) 1993-03-24

Similar Documents

Publication Publication Date Title
ATE145899T1 (de) Trimetazidinederivate, verfahren zu deren herstellung und deren pharmazeutischen zusammensetzungen
DE69110625D1 (de) Oxazolopyridinderivate, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen Zusammensetzungen.
DE69111582D1 (de) 1,4-Disubstituierte Piperazine, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
ATE1288T1 (de) Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
ZA934143B (en) 1,4-disubstituted piperazines, a process for their preparation and pharmaceutical compositions containing them
PT76336A (de) Cephalosporinderivate und verfahren zu ihrer herstellung
ATE10368T1 (de) Uracilderivate, verfahren zu ihrer herstellung und eine diese enthaltende pharmazeutische zubereitung.
ATE113595T1 (de) Spiro(4,5>decanderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE193531T1 (de) Phenyl-carboxamide-isoxazole-derivate und salze, verfahren zu ihrer herstellung ihre anwendung als arzneimittel und pharmazeutische zusammensetzungen die sie enthalten
ATE118759T1 (de) Ethanolaminbenzoatderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE73785T1 (de) 5-(3-alkyl-5-tert.butyl-4-hydroxyphenyl)-2-amin - 6h-1,3,4-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
IL69683A0 (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
ATE172976T1 (de) 3-aminochroman-spiroderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69104286D1 (de) Disubstituierte Polymethylenimine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel.
ATE3549T1 (de) Theophyllin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
ATE7902T1 (de) Benzamido-alkyl-hydroxamsaeurederivate, verfahren zu ihrer herstellung und pharmazeutische mittel.
DE69008489D1 (de) Morpholinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
ATE115118T1 (de) Benzoesäureethanolaminesterderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE13181T1 (de) Pyridazinonimine und ihre physiologisch vertraeglichen saeureadditionssalze, verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel.
KR900014372A (ko) 티에닐피페라진 이의 제조방법 및 이를 함유하는 약제
DE69211773D1 (de) Amidderivate von 1-Amino-Octahydropyrido[2,1-c][1,4]oxazin, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
DE69403606D1 (de) Cyclizierte Analoge der Fettsäurenmetaboliten, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee